525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors

التفاصيل البيبلوغرافية
العنوان: 525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors
المؤلفون: Symeonides, Stefan, Mahalingam, Devalingam, Chae, Young Kwang, Calvo, Emiliano, Miguel, Maria, Arkenau, Hendrik-Tobias, Garralda, Elena, Galvao, Vladimir, Mita, Alain, Hassan, Hariz, Baumhauer, Annette, Völker, Timo, Kühnle, Marie-Cristine, Rösemann, Roman, Strobl, Stefan, Tuereci, Oezlem, Sahin, Ugur
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2021
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2021-sitc2021.525
DOI: 10.1136/jitc-2021-SITC2021.525
الإتاحة: https://doi.org/10.1136/jitc-2021-sitc2021.525Test
رقم الانضمام: edsbas.555A14EE
قاعدة البيانات: BASE